|
2022 |
Procurement of Hepatitis B Surface Antigen Rapid Diagnostic Test - Rebid |
IB No. 2022-154-A |
15,000,000.00 |
25,000.00 |
May 19, 2022, 10:00 am |
June 2, 2022, 9:00 am |
May 11, 2022 |
|
2021 |
Procurement of Rare Blood Group Antisera for Fully Automated Immunophenotyping with Machine Tie-Up |
IB NO. 2021-206 |
42,500,000.00 |
25,000.00 |
July 5, 2021, 10:00 am |
July 19, 2021, 9:00 am |
June 25, 2021 |
|
2022 |
Procurement of Bivalent Oral Polio Vaccine |
IB No. 2022-046 |
41,805,000.00 |
25,000.00 |
February 10, 2022, 10:00 am |
February 23, 2022, 9:00 am |
February 2, 2022 |
|
2023 |
Procurement of the Structural Assessment, Design, and Retrofitting Including Repair/Renovation of DOH Building No.1 |
IB No. CW-2023-002 |
20,000,000.00 |
25,000.00 |
January 30, 2023, 10:00 am |
February 13, 2023, 9:00 am |
January 22, 2023 |
|
2023 |
Procurement of Radio Placement for Various Programs/Campaign |
IB No. 2023-021 |
20,000,000.00 |
25,000.00 |
November 23, 2022, 10:00 am |
December 7, 2022, 9:00 am |
November 14, 2022 |
|
2022 |
Procurement of Dengue RDT Kits |
IB No. 2022-142 |
38,400,000.00 |
25,000.00 |
March 10, 2022, 10:00 am |
March 24, 2022, 9:00 am |
March 2, 2022 |
|
2023 |
Procurement of Novaluron 10% |
IB No. 2023-064 |
30,330,000.00 |
25,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 29, 2022 |
|
2021 |
Procurement of Transfusion Transmissible Infection (TTIs) Reagents with Machine Tie-up-Rebid |
IB No. 2021-232-A |
14,180,400.00 |
25,000.00 |
October 14, 2021, 10:00 am |
October 28, 2021, 9:00 am |
October 6, 2021 |
|
2023 |
Procurement of Gemcitabine |
IB No. 2023-043 |
21,495,286.00 |
25,000.00 |
December 7, 2022, 10:00 am |
December 21, 2022, 9:00 am |
November 22, 2022 |
|
2023 |
Procurement of the Structural Assessment, Design, and Retrofitting Including Repair/Renovation of Bldg. 12 Phase 1 (MST and SCMS Office), DOH Central Office |
IB No. CW-2023-003 |
30,000,000.00 |
25,000.00 |
January 30, 2023, 10:00 am |
February 13, 2023, 9:00 am |
January 22, 2023 |
